Bob D Brown Dicerna Pharmaceuticals Inc (DRNA) insider trading activity

Bob D Brown is Chief Scientific Ofr., EVP R&D of Dicerna Pharmaceuticals Inc. Currently has a direct ownership of 0 shares of DRNA, which is worth approximately $0. The most recent transaction as insider was on Dec 28, 2021, when has been sold 2,367 shares (Common Stock) at a price of $38.25 per share, resulting in proceeds of $90,538. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Bob D Brown Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 28 2021	SELL Disposition due to a tender of shares in a change of control transaction	$90,538 $38.25 p/Share	2,367 Reduced 100.0%	0 Common Stock
Dec 15 2021	SELL Payment of exercise price or tax liability	$63,734 $38.05 p/Share	1,675 Reduced 41.44%	2,367 Common Stock
Dec 15 2021	BUY Exercise of conversion of derivative security	-	3,775 Added 48.29%	4,042 Common Stock
Nov 18 2021	SELL Open market or private sale	$946,072 $37.94 p/Share	24,936 Reduced 98.94%	267 Common Stock
Nov 18 2021	BUY Exercise of conversion of derivative security	$85,281 $3.42 p/Share	24,936 Added 49.73%	25,203 Common Stock
Sep 17 2021	SELL Open market or private sale	$447,525 $21.06 p/Share	21,250 Reduced 98.76%	267 Common Stock
Aug 02 2021	SELL Open market or private sale	$310,703 $37.38 p/Share	8,312 Reduced 27.87%	21,517 Common Stock
Aug 02 2021	BUY Exercise of conversion of derivative security	$28,427 $3.42 p/Share	8,312 Added 21.79%	29,829 Common Stock
Jul 01 2021	SELL Open market or private sale	$312,282 $37.57 p/Share	8,312 Reduced 27.87%	21,517 Common Stock
Jul 01 2021	BUY Exercise of conversion of derivative security	$28,427 $3.42 p/Share	8,312 Added 21.79%	29,829 Common Stock
Jun 11 2021	SELL Open market or private sale	$340,000 $34.0 p/Share	10,000 Reduced 31.73%	21,517 Common Stock
Jun 11 2021	BUY Exercise of conversion of derivative security	$90,900 $9.09 p/Share	10,000 Added 24.09%	31,517 Common Stock
Jun 07 2021	SELL Open market or private sale	$330,000 $33.0 p/Share	10,000 Reduced 31.73%	21,517 Common Stock
Jun 07 2021	BUY Exercise of conversion of derivative security	$90,900 $9.09 p/Share	10,000 Added 24.09%	31,517 Common Stock
Jun 01 2021	SELL Open market or private sale	$261,412 $31.45 p/Share	8,312 Reduced 27.87%	21,517 Common Stock
Jun 01 2021	BUY Exercise of conversion of derivative security	$28,427 $3.42 p/Share	8,312 Added 21.79%	29,829 Common Stock
May 03 2021	SELL Open market or private sale	$257,173 $30.94 p/Share	8,312 Reduced 27.87%	21,517 Common Stock
May 03 2021	BUY Exercise of conversion of derivative security	$28,427 $3.42 p/Share	8,312 Added 21.79%	29,829 Common Stock
Apr 30 2021	SELL Open market or private sale	$320,000 $32.0 p/Share	10,000 Reduced 31.73%	21,517 Common Stock
Apr 30 2021	BUY Exercise of conversion of derivative security	$90,900 $9.09 p/Share	10,000 Added 24.09%	31,517 Common Stock
Apr 29 2021	SELL Open market or private sale	$310,000 $31.0 p/Share	10,000 Reduced 31.73%	21,517 Common Stock
Apr 29 2021	BUY Exercise of conversion of derivative security	$90,900 $9.09 p/Share	10,000 Added 24.09%	31,517 Common Stock
Apr 01 2021	SELL Open market or private sale	$217,608 $26.18 p/Share	8,312 Reduced 27.87%	21,517 Common Stock
Apr 01 2021	BUY Exercise of conversion of derivative security	$28,427 $3.42 p/Share	8,312 Added 21.79%	29,829 Common Stock
Mar 01 2021	SELL Open market or private sale	$242,710 $29.2 p/Share	8,312 Reduced 27.87%	21,517 Common Stock

BDB

Bob D Brown

Chief Scientific Ofr., EVP R&D

Lexington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Dicerna Pharmaceuticals Inc insider buys or sells DRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Dicerna Pharmaceuticals Inc

Track Activities on DRNA

Account